샘플 요청 목록

 카트 문의
시장보고서
상품코드
1791794

세계의 롱리드 시퀀싱 시장

Long Read Sequencing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 579 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 롱리드 시퀀싱 시장은 2030년까지 38억 달러에 이를 전망

2024년에 7억 5,680만 달러로 추정되는 롱리드 시퀀싱 세계 시장은 분석 기간인 2024-2030년 CAGR 30.8%로 성장하여 2030년에는 38억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 기기는 CAGR 32.5%를 나타내고, 분석 기간 종료시에는 26억 달러에 이를 것으로 예측됩니다. 소모품 부문의 성장률은 분석 기간중 CAGR 28.3%로 추정됩니다.

미국 시장은 추정 2억 620만 달러, 중국은 CAGR 40.4%로 성장 예측

미국의 롱리드 시퀀싱 시장은 2024년에 2억 620만 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 분석 기간인 2024-2030년간 CAGR 40.4%로 2030년까지 9억 7,320만 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 24.7%와 27.9%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 26.1%를 보일 전망입니다.

세계의 롱리드 시퀀싱 시장 - 주요 동향과 촉진요인 정리

롱리드 시퀀싱는 무엇이며, 왜 유전체학에 혁명을 가져올 것인가?

롱리드 시퀀싱은 3세대 시퀀서라고도 불리며, 한 번에 수만 염기쌍 이상의 염기서열을 읽을 수 있는 첨단 DNA 염기서열 분석 기술을 말합니다. DNA 단편을 작은 비트(보통 100-300 염기쌍)로 읽는 숏리드 시퀀싱와 달리 롱리드 시퀀싱는 숏리드 기술로는 효과적으로 해결할 수 없는 반복적인 영역이나 복잡한 영역에 걸쳐 있어 보다 완전하고 정확한 유전체의 이미지를 제공합니다. 따라서 de novo 유전체 어셈블리, 구조적 변이체 검출, 후성유전학적 분석, 미해석 유전체 영역의 연구에 특히 유용합니다.

Pacific Biosciences(PacBio) 및 Oxford Nanopore Technologies(ONT)와 같은 공급업체가 제공하는 기술은 이 분야의 최전선에 있으며, 롱리드 분석을 위한 확장성이 뛰어나고 점점 더 비용 효율적인 솔루션을 제공합니다. 솔루션을 제공합니다. 이러한 플랫폼은 인간 질병, 미생물 군집, 식물 유전체, 암 유전체에 대한 종합적인 통찰을 가능하게 함으로써 유전체 연구와 임상 진단에 변화를 가져오고 있습니다. 전장 전사체 및 메틸화 패턴을 포착하는 능력도 기능 유전체학 및 전사체 프로파일링을 강화합니다. 보다 정확하고 완전한 유전자 데이터에 대한 수요가 증가함에 따라 롱리드 시퀀싱은 현대 분자생물학에서 점점 더 중심적인 역할을 하고 있습니다.

어떤 혁신과 이용 사례가 롱리드 시퀀싱의 채택을 가속화하고 있는가?

롱리드 시퀀싱의 진화는 리드 정확도, 처리량, 휴대성의 지속적인 발전에 의해 형성되고 있습니다. PacBio의 HiFi 리드와 Oxford Nanopore의 Q20+ 케미스트리의 최근 개선으로 롱리드의 베이스 콜 정확도가 크게 향상되어 정확도와 신뢰성 측면에서 숏리드 플랫폼과 경쟁할 수 있게 되었습니다. 이러한 기술 혁신으로 롱리드 시퀀싱은 구조적 변이, 유전자 융합, 대규모 삽입 및 결실의 정확한 검출이 중요한 임상 진단, 맞춤 의료, 희귀질환의 식별에 폭넓게 적용될 수 있게 되었습니다.

롱리드 기술은 마이크로바이옴 분석과 메타유전체 분석에도 점점 더 많이 활용되고 있으며, 복잡한 시료에서 미생물 유전체를 완전히 분석할 수 있는 능력으로 미생물의 다양성, 항생제 내성, 병원체 모니터링에 대한 이해가 깊어지고 있습니다. 종양학에서는 롱리드가 종양의 이질성이나 체세포 구조의 돌연변이 검출에 도움이 되어 치료 방침을 결정하는 데 도움이 되고 있습니다. ONT의 MinION 디바이스와 같은 플랫폼의 휴대성은 감염성 추적, 환경유전체학, 식품안전 검사 등 현장 및 현장 진료 현장에서의 시퀀싱을 가능하게 합니다. 또한, 롱리드 시퀀싱은 특히 집단 규모의 유전체 프로젝트에서 비용, 정확도, 커버리지 깊이의 균형을 맞추기 위해 롱리드와 숏 리드를 결합한 하이브리드 시퀀싱 전략에 통합되어 있습니다.

롱리드 시퀀싱 시장 확대 요인은?

세계 롱리드 시퀀싱 시장의 성장은 종합적인 유전체 지식에 대한 수요 증가, 시퀀싱 비용 감소, 임상 및 농업 유전체학 분야에서의 적용 확대 등 여러 요인에 의해 주도되고 있습니다. 연구자와 임상의들이 복잡한 유전자 영역과 구조적 변이를 해독하고자 하는 가운데, 짧은 리드 시퀀싱에서 놓치기 쉬운 보다 정확하고 완전한 유전체 프로파일링을 위해 롱리드 플랫폼의 채택이 증가하고 있습니다. 이러한 수요는 유전체의 복잡성으로 인해 고해상도 분석이 필요한 종양학, 희귀질환 진단, 신경유전학, 산전 스크리닝 분야에서 특히 두드러지게 나타나고 있습니다.

또한, 개인 맞춤형 의료와 정밀의료의 확산으로 개인별 유전체 데이터로부터 실용적인 지식을 얻을 수 있는 기술의 필요성이 높아지고 있습니다. 집단 시퀀싱 프로젝트, 희귀질환 등록 등 정부가 지원하는 유전체 관련 이니셔티브도 데이터의 무결성과 유용성을 보장하기 위해 롱리드 플랫폼을 도입하여 시장 성장에 기여하고 있습니다. 또한, 농업생명공학 및 식물성 기름전체학에 대한 투자가 증가함에 따라 작물 형질 분석, 유전체 편집 검증, 생물다양성 연구에 롱리드의 활용이 확대되고 있습니다. 시퀀싱 화학, 기기 소형화, 클라우드 기반 바이오인포매틱스 분야의 지속적인 기술 혁신은 신규 사용자의 진입 장벽을 낮추고, 학술, 임상, 상업적 영역에서 시장 도입을 더욱 가속화하고 있습니다.

부문

제품(기기, 소모품, 서비스); 기술(단일 분자 실시간 시퀀싱, 나노 기공 시퀀싱, 기타); 워크플로(사전 시퀀싱, 시퀀싱, 데이터 분석); 애플리케이션(전체 유전체 시퀀싱, 표적 시퀀싱, 메타게놈학, RNA 시퀀싱, 후성 유전학, 기타); 최종 용도(학술 및 연구 기관, 병원 및 클리닉, 제약 및 생명공학 기업, 기타).

조사 대상 기업 예

  • 10x Genomics
  • Agilent Technologies
  • BGI Genomics
  • Bionano Genomics
  • CD Genomics
  • Element Biosciences
  • FG Technologies
  • GENEWIZ(Azenta Life Sciences)
  • Illumina, Inc.
  • MGI Tech Co., Ltd.
  • MicrobesNG
  • Oxford Nanopore Technologies
  • Pacific Biosciences(PacBio)
  • Qiagen
  • Quantapore, Inc.
  • Singular Genomics
  • Stratos Genomics
  • Thermo Fisher Scientific
  • Ultima Genomics
  • Universal Sequencing Technology Corp.

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 큐레이트된 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.08.21

Global Long Read Sequencing Market to Reach US$3.8 Billion by 2030

The global market for Long Read Sequencing estimated at US$756.8 Million in the year 2024, is expected to reach US$3.8 Billion by 2030, growing at a CAGR of 30.8% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 32.5% CAGR and reach US$2.6 Billion by the end of the analysis period. Growth in the Consumables segment is estimated at 28.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$206.2 Million While China is Forecast to Grow at 40.4% CAGR

The Long Read Sequencing market in the U.S. is estimated at US$206.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$973.2 Million by the year 2030 trailing a CAGR of 40.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 24.7% and 27.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 26.1% CAGR.

Global Long Read Sequencing Market - Key Trends & Drivers Summarized

What Is Long Read Sequencing and Why Is It Revolutionizing Genomics?

Long read sequencing, also known as third-generation sequencing, refers to advanced DNA sequencing technologies capable of reading extended nucleotide sequences in a single pass-often exceeding tens of thousands of base pairs. Unlike short-read sequencing, which reads DNA fragments in small bits (typically 100-300 base pairs), long read sequencing provides a more complete and accurate picture of the genome by spanning repetitive and complex regions that short-read technologies cannot resolve effectively. This makes it especially valuable for de novo genome assembly, structural variant detection, epigenetic analysis, and studying previously uncharacterized genomic regions.

Technologies from providers like Pacific Biosciences (PacBio) and Oxford Nanopore Technologies (ONT) are at the forefront of this field, offering highly scalable and increasingly cost-effective solutions for long read analysis. These platforms are transforming genomics research and clinical diagnostics by enabling comprehensive insights into human diseases, microbial communities, plant genomics, and cancer genomics. Their ability to capture full-length transcripts and methylation patterns also enhances functional genomics and transcriptome profiling. As the demand for more precise and complete genetic data grows, long read sequencing is playing an increasingly central role in modern molecular biology.

What Innovations and Use Cases Are Accelerating the Adoption of Long Read Sequencing?

The evolution of long read sequencing is being shaped by continuous advancements in read accuracy, throughput, and portability. Recent iterations of PacBio's HiFi reads and Oxford Nanopore’s Q20+ chemistry have significantly improved the base-calling accuracy of long reads, making them competitive with short-read platforms in both precision and reliability. These innovations have expanded long read sequencing’s applicability across clinical diagnostics, personalized medicine, and rare disease identification, where accurate detection of structural variants, gene fusions, and large insertions or deletions is critical.

Long read technologies are also being increasingly used in microbiome analysis and metagenomics, where the ability to fully resolve microbial genomes from complex samples enhances the understanding of microbial diversity, antibiotic resistance, and pathogen surveillance. In oncology, long reads are aiding in the detection of tumor heterogeneity and somatic structural variations that inform treatment decisions. The portability of platforms like ONT’s MinION device is enabling in-field and point-of-care sequencing for infectious disease tracking, environmental genomics, and food safety testing. Furthermore, long read sequencing is being integrated into hybrid sequencing strategies-combining long and short reads-to balance cost, accuracy, and depth of coverage, particularly in population-scale genome projects.

What Factors Are Fueling the Expansion of the Long Read Sequencing Market?

The growth in the global long read sequencing market is driven by several factors, including increasing demand for comprehensive genomic insights, declining sequencing costs, and expanding applications in clinical and agricultural genomics. As researchers and clinicians seek to decode complex genetic regions and structural variations that short-read sequencing often misses, long read platforms are being increasingly adopted for more accurate and complete genomic profiling. This demand is particularly pronounced in oncology, rare disease diagnostics, neurogenetics, and prenatal screening, where genomic complexity requires high-resolution analysis.

In addition, the rising prevalence of personalized and precision medicine is catalyzing the need for technologies that can deliver actionable insights from individual genomic data. Government-backed genomic initiatives, such as national population sequencing projects and rare disease registries, are also contributing to market growth by incorporating long read platforms to ensure data completeness and utility. Moreover, growing investments in agricultural biotechnology and plant genomics are expanding the use of long reads in crop trait analysis, genome editing validation, and biodiversity studies. The continuous innovation in sequencing chemistry, device miniaturization, and cloud-based bioinformatics is lowering the entry barrier for new users, further accelerating market adoption across academic, clinical, and commercial domains.

SCOPE OF STUDY:

The report analyzes the Long Read Sequencing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Instruments, Consumables, Services); Technology (Single Molecule Real Time Sequencing, Nanopore Sequencing, Others); Workflow (Pre-sequencing, Sequencing, Data Analysis); Application (Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics, Others); End-Use (Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • 10x Genomics
  • Agilent Technologies
  • BGI Genomics
  • Bionano Genomics
  • CD Genomics
  • Element Biosciences
  • FG Technologies
  • GENEWIZ (Azenta Life Sciences)
  • Illumina, Inc.
  • MGI Tech Co., Ltd.
  • MicrobesNG
  • Oxford Nanopore Technologies
  • Pacific Biosciences (PacBio)
  • Qiagen
  • Quantapore, Inc.
  • Singular Genomics
  • Stratos Genomics
  • Thermo Fisher Scientific
  • Ultima Genomics
  • Universal Sequencing Technology Corp.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Long Read Sequencing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rapid Advancements in Third-Generation Sequencing Technologies Propel Market Expansion
    • Growing Demand for Accurate Structural Variant Detection Drives Adoption of Long Read Platforms
    • Rising Genomic Research Funding Worldwide Accelerates Technology Penetration
    • Need for Complete and Unbiased Genome Assembly Expands Use in Complex Genomic Regions
    • Integration with CRISPR-Based Applications Enhances Relevance in Functional Genomics
    • Increased Use in Oncology and Rare Disease Diagnostics Strengthens Clinical Utility
    • Bioinformatics Advancements Improve Accuracy and Cost-Efficiency of Data Interpretation
    • Collaborations Between Academic Labs and Sequencing Companies Accelerate Innovation Cycles
    • Expanding Role in Microbiome and Metagenomics Research Drives Application Breadth
    • Global Precision Medicine Initiatives Fuel Demand for Long Read Sequencing Tools
    • Use in Epigenetics and Methylation Analysis Expands Research Applications
    • Hybrid Sequencing Approaches (Short + Long Reads) Gain Momentum for Comprehensive Analysis
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Long Read Sequencing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Long Read Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Long Read Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Long Read Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Targeted Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Targeted Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Targeted Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Metagenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Metagenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Metagenomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for RNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for RNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for RNA Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Epigenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Single Molecule Real Time Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Single Molecule Real Time Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Single Molecule Real Time Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Nanopore Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Nanopore Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: World 15-Year Perspective for Nanopore Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 53: World Recent Past, Current & Future Analysis for Pre-sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: World Historic Review for Pre-sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: World 15-Year Perspective for Pre-sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 56: World Recent Past, Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: World Historic Review for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: World 15-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 59: World Recent Past, Current & Future Analysis for Data Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 60: World Historic Review for Data Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: World 15-Year Perspective for Data Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 62: USA Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: USA 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 65: USA Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: USA Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: USA 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 68: USA Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: USA Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: USA 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 71: USA Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: USA Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: USA 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 74: USA Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: USA Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: USA 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 77: Canada Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Canada Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Canada 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 80: Canada Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Canada Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Canada 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 83: Canada Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Canada Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Canada 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 86: Canada Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Canada Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Canada 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 89: Canada Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Canada Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Canada 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • JAPAN
    • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 92: Japan Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Japan Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Japan 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 95: Japan Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Japan Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Japan 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 98: Japan Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Japan Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Japan 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 101: Japan Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Japan Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Japan 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 104: Japan Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Japan Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Japan 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • CHINA
    • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 107: China Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: China Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: China 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 110: China Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: China Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: China 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 113: China Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: China Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: China 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 116: China Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: China Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: China 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 119: China Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: China Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: China 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • EUROPE
    • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 122: Europe Recent Past, Current & Future Analysis for Long Read Sequencing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 123: Europe Historic Review for Long Read Sequencing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Europe 15-Year Perspective for Long Read Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 125: Europe Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Europe Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Europe 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 128: Europe Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Europe Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Europe 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 131: Europe Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Europe Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Europe 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 134: Europe Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Europe Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Europe 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 137: Europe Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Europe Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Europe 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • FRANCE
    • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 140: France Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: France Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: France 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 143: France Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: France Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: France 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 146: France Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: France Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: France 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 149: France Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: France Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: France 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 152: France Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: France Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: France 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • GERMANY
    • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 155: Germany Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Germany Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Germany 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 158: Germany Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Germany Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Germany 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 161: Germany Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Germany Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Germany 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 164: Germany Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Germany Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Germany 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 167: Germany Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Germany Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Germany 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 170: Italy Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Italy Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Italy 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 173: Italy Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Italy Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Italy 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 176: Italy Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Italy Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Italy 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 179: Italy Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Italy Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Italy 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 182: Italy Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Italy Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Italy 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 185: UK Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: UK Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: UK 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 188: UK Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UK Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: UK 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 191: UK Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UK Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UK 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 194: UK Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UK Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UK 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 197: UK Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UK Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UK 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 200: Spain Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Spain Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Spain 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 203: Spain Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Spain Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Spain 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 206: Spain Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Spain Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Spain 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 209: Spain Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Spain Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Spain 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 212: Spain Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Spain Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Spain 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 215: Russia Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Russia Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Russia 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 218: Russia Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Russia Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Russia 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 221: Russia Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Russia Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Russia 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 224: Russia Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Russia Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Russia 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 227: Russia Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Russia Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Russia 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 230: Rest of Europe Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Europe Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Europe 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Europe Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Europe Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Europe 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Europe Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Europe Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Europe 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Europe Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Europe Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Europe 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Europe Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Europe Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Europe 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 245: Asia-Pacific Recent Past, Current & Future Analysis for Long Read Sequencing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 246: Asia-Pacific Historic Review for Long Read Sequencing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Asia-Pacific 15-Year Perspective for Long Read Sequencing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 248: Asia-Pacific Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Asia-Pacific Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Asia-Pacific 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 251: Asia-Pacific Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Asia-Pacific Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Asia-Pacific 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 254: Asia-Pacific Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Asia-Pacific Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Asia-Pacific 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 257: Asia-Pacific Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Asia-Pacific Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Asia-Pacific 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 260: Asia-Pacific Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Asia-Pacific Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Asia-Pacific 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 263: Australia Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Australia Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Australia 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 266: Australia Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Australia Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Australia 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 269: Australia Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Australia Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Australia 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 272: Australia Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Australia Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Australia 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 275: Australia Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Australia Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Australia 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • INDIA
    • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 278: India Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: India Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: India 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 281: India Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: India Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: India 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 284: India Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: India Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: India 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 287: India Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: India Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: India 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 290: India Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: India Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: India 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 293: South Korea Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: South Korea Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: South Korea 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 296: South Korea Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: South Korea Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: South Korea 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 299: South Korea Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: South Korea Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: South Korea 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 302: South Korea Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: South Korea Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: South Korea 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 305: South Korea Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: South Korea Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: South Korea 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 308: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Asia-Pacific Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Asia-Pacific 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 311: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Rest of Asia-Pacific Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: Rest of Asia-Pacific 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 314: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Rest of Asia-Pacific Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 316: Rest of Asia-Pacific 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 317: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Rest of Asia-Pacific Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 319: Rest of Asia-Pacific 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 320: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Rest of Asia-Pacific Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 322: Rest of Asia-Pacific 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 323: Latin America Recent Past, Current & Future Analysis for Long Read Sequencing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 324: Latin America Historic Review for Long Read Sequencing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 325: Latin America 15-Year Perspective for Long Read Sequencing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 326: Latin America Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Latin America Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 328: Latin America 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 329: Latin America Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Latin America Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 331: Latin America 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 332: Latin America Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Latin America Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 334: Latin America 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 335: Latin America Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Latin America Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 337: Latin America 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 338: Latin America Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Latin America Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 340: Latin America 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 341: Argentina Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Argentina Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 343: Argentina 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 344: Argentina Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Argentina Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 346: Argentina 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 347: Argentina Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Argentina Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 349: Argentina 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 350: Argentina Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Argentina Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 352: Argentina 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 353: Argentina Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Argentina Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 355: Argentina 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 356: Brazil Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Brazil Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 358: Brazil 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 359: Brazil Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Brazil Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 361: Brazil 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 362: Brazil Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Brazil Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 364: Brazil 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 365: Brazil Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Brazil Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 367: Brazil 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 368: Brazil Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Brazil Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 370: Brazil 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 371: Mexico Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Mexico Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 373: Mexico 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 374: Mexico Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Mexico Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 376: Mexico 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 377: Mexico Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Mexico Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 379: Mexico 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 380: Mexico Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Mexico Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 382: Mexico 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 383: Mexico Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Mexico Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 385: Mexico 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 386: Rest of Latin America Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Rest of Latin America Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 388: Rest of Latin America 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 389: Rest of Latin America Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Rest of Latin America Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 391: Rest of Latin America 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 392: Rest of Latin America Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Rest of Latin America Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 394: Rest of Latin America 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 395: Rest of Latin America Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Rest of Latin America Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 397: Rest of Latin America 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 398: Rest of Latin America Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Rest of Latin America Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 400: Rest of Latin America 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 401: Middle East Recent Past, Current & Future Analysis for Long Read Sequencing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 402: Middle East Historic Review for Long Read Sequencing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 403: Middle East 15-Year Perspective for Long Read Sequencing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 404: Middle East Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 405: Middle East Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 406: Middle East 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 407: Middle East Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 408: Middle East Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 409: Middle East 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 410: Middle East Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 411: Middle East Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 412: Middle East 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 413: Middle East Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 414: Middle East Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 415: Middle East 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 416: Middle East Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 417: Middle East Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 418: Middle East 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 419: Iran Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 420: Iran Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 421: Iran 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 422: Iran Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 423: Iran Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 424: Iran 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 425: Iran Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 426: Iran Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 427: Iran 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 428: Iran Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 429: Iran Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 430: Iran 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 431: Iran Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 432: Iran Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 433: Iran 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 434: Israel Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 435: Israel Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 436: Israel 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 437: Israel Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 438: Israel Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 439: Israel 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 440: Israel Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 441: Israel Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 442: Israel 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 443: Israel Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 444: Israel Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 445: Israel 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 446: Israel Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 447: Israel Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 448: Israel 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 449: Saudi Arabia Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 450: Saudi Arabia Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 451: Saudi Arabia 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 452: Saudi Arabia Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 453: Saudi Arabia Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 454: Saudi Arabia 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 455: Saudi Arabia Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 456: Saudi Arabia Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 457: Saudi Arabia 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 458: Saudi Arabia Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 459: Saudi Arabia Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 460: Saudi Arabia 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 461: Saudi Arabia Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 462: Saudi Arabia Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 463: Saudi Arabia 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 464: UAE Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 465: UAE Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 466: UAE 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 467: UAE Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 468: UAE Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 469: UAE 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 470: UAE Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 471: UAE Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 472: UAE 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 473: UAE Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 474: UAE Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 475: UAE 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 476: UAE Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 477: UAE Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 478: UAE 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 479: Rest of Middle East Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 480: Rest of Middle East Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 481: Rest of Middle East 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 482: Rest of Middle East Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 483: Rest of Middle East Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 484: Rest of Middle East 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 485: Rest of Middle East Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 486: Rest of Middle East Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 487: Rest of Middle East 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 488: Rest of Middle East Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 489: Rest of Middle East Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 490: Rest of Middle East 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 491: Rest of Middle East Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 492: Rest of Middle East Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 493: Rest of Middle East 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030
  • AFRICA
    • Long Read Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 494: Africa Recent Past, Current & Future Analysis for Long Read Sequencing by Product - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 495: Africa Historic Review for Long Read Sequencing by Product - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 496: Africa 15-Year Perspective for Long Read Sequencing by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 497: Africa Recent Past, Current & Future Analysis for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 498: Africa Historic Review for Long Read Sequencing by Application - Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 499: Africa 15-Year Perspective for Long Read Sequencing by Application - Percentage Breakdown of Value Sales for Whole Genome Sequencing, Targeted Sequencing, Metagenomics, RNA Sequencing, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 500: Africa Recent Past, Current & Future Analysis for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 501: Africa Historic Review for Long Read Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 502: Africa 15-Year Perspective for Long Read Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 503: Africa Recent Past, Current & Future Analysis for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 504: Africa Historic Review for Long Read Sequencing by Technology - Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 505: Africa 15-Year Perspective for Long Read Sequencing by Technology - Percentage Breakdown of Value Sales for Single Molecule Real Time Sequencing, Nanopore Sequencing and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 506: Africa Recent Past, Current & Future Analysis for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 507: Africa Historic Review for Long Read Sequencing by Workflow - Pre-sequencing, Sequencing and Data Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 508: Africa 15-Year Perspective for Long Read Sequencing by Workflow - Percentage Breakdown of Value Sales for Pre-sequencing, Sequencing and Data Analysis for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제